Comparison of the Vitek 2 antifungal susceptibility system with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1782-1786

  Cuenca Estrella, Manuel ^a   Gomez Lopez, Alicia ^a   Alastruey Izquierdo, Ana ^a   Bernal Martinez, Leticia ^a   Cuesta, Isabel ^a   Buitrago, Maria J ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CLINICAL AND LABORATORY STANDARDS INSTITUTE TECHNIQUE; CLINICAL EXAMINATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; EPSILOMETER TEST; EUROPEAN COMMITTEE ON ANTIMICROBIAL SUSCEPTIBILITY TESTING; FUNGAL STRAIN; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; SENSITITER YEASTONE TEST; STANDARD; VITEK 2 ANTIFUNGAL SUSCEPTIBILITY SYSTEM;

ANTIFUNGAL AGENTS; DIAGNOSTIC ERRORS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; TIME FACTORS; YEASTS;

CANDIDA; FILOBASIDIELLA NEOFORMANS;

EID: 77951836965     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02316-09     Document Type: Article

References (23)

1. Al-Sweih, N., S. Ahmad, Z. U. Khan, S. Khan, and R. Chandy. 2005. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 48:347-351. (Pubitemid 41656983)
2. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A2, 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A3, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M. J. Buitrago, A. Monzon, and J. L. Rodriguez-Tudela. 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother. 50:917-921.
5. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, and J. L. Rodriguez-Tudela. 2005. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin. Microbiol. Infect. 11:486-492.
6. Cuenca-Estrella, M., W. Lee-Yang, M. A. Ciblak, B. A. Arthington-Skaggs, E. Mellado, D. W. Warnock, and J. L. Rodriguez-Tudela. 2002. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother. 46:3644-3647.
7. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueres. 2000. Atlas of clinical fungi. Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, Utrecht, Netherlands.
8. Espinel-Ingroff, A., F. Barchiesi, M. Cuenca-Estrella, M. A. Pfaller, M. Rinaldi, J. L. Rodriguez-Tudela, and P. E. Verweij. 2005. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J. Clin. Microbiol. 43:3884-3889.
9. Gomez-Lopez, A., O. Zaragoza, M. M. Dos Anjos, M. C. Melhem, J. L. Rodriguez-Tudela, and M. Cuenca-Estrella. 2008. In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin. Microbiol. Infect. 14:727-730.
10. Kurtzman, C. P., and J. W. Fell. 1998. The yeasts. A taxonomic study. Elsevier, Amsterdam, Netherlands.
11. Mokaddas, E. M., N. A. Al Sweih, and Z. U. Khan. 2007. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. J. Med. Microbiol. 56:255-259.
12. Perkins, A., A. Gomez-Lopez, E. Mellado, J. L. Rodriguez-Tudela, and M. Cuenca-Estrella. 2005. Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J. Antimicrob. Chemother. 56:1144-1147.
13. Pfaller, M. A., D. J. Diekema, G. W. Procop, and M. G. Rinaldi. 2007. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J. Clin. Microbiol. 45:3522-3528.
14. Pfaller, M. A., D. J. Diekema, G. W. Procop, and M. G. Rinaldi. 2007. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J. Clin. Microbiol. 45:796-802.
15. Posteraro, B., R. Martucci, M. La Sorda, B. Fiori, D. Sanglard, E. De Carolis, A. R. Florio, G. Fadda, and M. Sanguinetti. 2009. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. J. Clin. Microbiol. 47:1927-1930.
16. Rodriguez-Tudela, J. L., F. Martin-Diez, M. Cuenca-Estrella, L. Rodero, Y. Carpintero, and B. Gorgojo. 2000. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob. Agents Chemother. 44:400-404.
17. Rodriguez-Tudela, J. L., M. C. Arendrup, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. W. Denning, J. P. Donnelly, F. Dromer, W. Fegeler, C. Lass-Florl, C. Moore, M. Richardson, P. Sandven, A. Velegraki, and P. Verweij. 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405.
18. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. Denning, W. Fegeler, P. Gaustad, C. Lass-Florl, C. Moore, M. Richardson, A. Schmalreck, A. Velegraki, and P. Verweij. 2008. EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clin. Microbiol. Infect. 14:982-984.
19. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. Denning, W. Fegeler, P. Gaustad, N. Klimko, C. Lass-Florl, C. Moore, M. Richardson, A. Schmalreck, J. Stenderup, A. Velegraki, and P. Verweij. 2008. EUCAST technical note on fluconazole. Clin. Microbiol. Infect. 14:193-195.
20. Rodriguez-Tudela, J. L., J. P. Donnelly, M. C. Arendrup, S. Arikan, F. Barchiesi, J. Bille, E. Chryssanthou, M. Cuenca-Estrella, E. Dannaoui, D. Denning, W. Fegeler, P. Gaustad, C. Lass-Florl, C. Moore, M. Richardson, A. Schmalreck, A. Velegraki, and P. Verweij. 2008. EUCAST technical note on voriconazole. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Clin. Microbiol. Infect. 14:985-987.
21. SPSS, Inc. 2009. Advanced statistical analysis. SPSS, Inc., Chicago, IL.
22. SPSS, Inc. 2009. Market segmentation. SPSS, Inc., Chicago, IL.
23. SPSS, Inc. 2009. Statistical analysis. SPSS, Inc., Chicago, IL.